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Abstract
In vitro display technologies such as mRNA display are powerful screening tools for protein interaction analysis, but the final
cloning and sequencing processes represent a bottleneck, resulting in many false negatives. Here we describe an
application of tiling array technology to identify specifically binding proteins selected with the in vitro virus (IVV) mRNA
display technology. We constructed transcription-factor tiling (TFT) arrays containing ,1,600 open reading frame sequences
of known and predicted mouse transcription-regulatory factors (334,372 oligonucleotides, 50-mer in length) to analyze
cDNA fragments from mRNA-display screening for Jun-associated proteins. The use of the TFT arrays greatly increased the
coverage of known Jun-interactors to 28% (from 14% with the cloning and sequencing approach), without reducing the
accuracy (,75%). This method could detect even targets with extremely low expression levels (less than a single mRNA
copy per cell in whole brain tissue). This highly sensitive and reliable method should be useful for high-throughput protein
interaction analysis on a genome-wide scale.
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Introduction
Protein display technologies [1], such as phage display [2],
ribosome display [3–5], DNA display [6] and mRNA display [7–9],
are powerful tools for construction and in vitro selection of large
libraries of genotype-phenotype conjugates. These libraries can be
affinity-screened via the protein moiety (phenotype) followed by
decodingofthenucleicacidmoiety(genotype)toidentifytheselected
proteins. These display technologies have been employed not only
for directed evolution of novel proteins and antibodies [10–12], but
also for the screening of protein-protein [13,14], protein-drug [15],
and protein-DNA [16] interactions from randomly fragmented
cDNA libraries. Development of totally in vitro display techniques,
such as ribosome display [3–5] and mRNA display [7–9], based on
cell-free translation systems has extended the scope of previous
techniques for protein interaction analysis using living cells, such as
the yeast two-hybrid method [17] and biochemical methods coupled
with mass spectrometry [18], because the variety of testable
interaction conditions is greater, and the in vitro techniques are
applicable to cytotoxic proteins.
However, the display technologies have a common bottleneck in
the final step of identifying the specifically selected protein
sequences. The decoding is usually achieved by cloning and
DNA sequencing, but the following difficulties arise: 1) Only a
limited number of clones can be analyzed, and thus positive
candidates whose contents in the selected library are less than a
threshold determined by the number of analyzed clones are lost as
false negatives. 2) Positive sequences with low contents in a library
can be enriched by iterative rounds of affinity-selection, but lower-
affinity binders compete with higher-affinity binders and therefore
drop out of the screening. 3) DNA fragments which are injurious
to cloning hosts, e.g., cytotoxic sequences, may be lost. 4) Cloning
and sequencing of a huge number of copies of selected sequences is
redundant, cost-ineffective, and time-consuming. Although novel
high-throughput DNA sequencing methods that require no
bacterial cloning process have recently been reported [19], these
techniques are not yet widely available.
To overcome the above limitations, we examined the use of a
DNA microarray technique as an alternative to the cloning and
sequencing processes (Figure 1). The combinatorial use of a tiling
array [20] representing ORF sequences with in vitro display
technology would provide a completely in vitro platform for highly
sensitive and parallel analysis of protein interactions. It should be
possible to detect enrichment of cDNA fragments of selected
candidates even with low contents or low affinity. In this report, we
demonstrate a highly sensitive analysis employing a transcription-
factor tiling (TFT) array for identifying Jun-associated proteins
selected with an mRNA display technology, in vitro virus (IVV)
[21,22], and show that the use of tiling arrays is indeed superior to
the use of cloning and sequencing for decoding genetic
information of proteins enriched by in vitro selection.
Methods
IVV screening
Preparation of bait template and IVV template libraries, and
the procedure of IVV screening were described in detail in our
previous report [21]. Details are also given in Methods S1 online.
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Oligonucleotide arrays were constructed photolithographically by
an oligo DNA microarray construction service (NimbleGen). The
sequences of 1,562 mouse transcription regulatory factors listed by
Gunji et al. [23], as well as 37 Jun-associated protein candidates
found in our previous studies [14,21,22], were collected from the
RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) and Genbank
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Nucleotide)
databases. Both strands of the total of 1,599 mRNA sequences were
doubly represented by a total of 334,372 oligo DNA probes 50-mer
in length, with no gap between the probes (Figure 1).
Sample labeling, hybridization and signal detection
Biotin-labeling of the samples was performed by means of in vitro
transcription from an SP6 promoter at the 59-end of each cDNA
fragment in the libraries, as described [24], with some modifica-
tions. In this process, biotin-labeled sense-strand RNA fragments
were produced. Thus, only the antisense-strand probe set was
further analyzed in this study. The labeled samples from the bait
(+) and bait (2) screening were hybridized separately on the tiling
arrays. The hybridized tiling arrays were stained with Cy3-
Streptavidin (Amersham) and detection was done with a scanner.
Details are given in Methods S1 online.
Data analysis
Collected data from the tiling array were normalized with the
mediancorrectionalgorithm.Ratiosofsignalvaluesbetweenthetwo
samples from bait (+)a n db a i t( 2) screenings were calculated (Data
S1 online). The ratio data were expressed as log2X( Xi st h ea c t u a l
measurement). After signal measurement, specific signal peaks were
identified by the ‘‘Windowed Threshold Detection’’ algorithm in
SignalMap software (NimbleGen). This algorithm looks for at least
four data points that are above a threshold value within a window.
These points were grouped together and presented as a peak. We
used the following parameters in the algorithm: Peak Window Size,
300 bp; Percent of Peak Threshold, 20% of maximum data in each
mRNAsequence.Thevalueofeachpeakwasthemaximumvalueof
the data points in that peak. Only reproducible peaks in the
duplicated data were collected as candidates for Jun interactors
(Table S1 online). A probe set for NM_183316 was not analyzed,
because the sequence of NM_183316 overlapped with that of
NM_025925 on the array.
Real-time PCR analysis
Real-time PCR was performed with SYBR Premix Ex Taq
(Takara) and protein-specific primer sets (Table S2 online) on the
LightCycler (Roche) as previously described [22]. The standard
Figure 1. Scheme of iterative screening for protein interactions using the IVV method and a tiling array. A cDNA library was transcribed
to an mRNA library, and then ligated with PEG Puro spacer [p(dCp)2-T(Fluor)p-PEGp-(dCp)2-puromycin] using T4 RNA ligase to prepare an IVV library.
In this study, bait protein fused with tandem affinity purification (TAP) tag was co-translated with the IVV library in a wheat germ extract cell-free
translation system. Complexes of bait protein and target IVV molecules were captured with affinity beads (IgG agarose) via the added TAP-tag. The
RNA portion of the captured IVVs was reverse-transcribed and PCR-amplified. Finally, screened cDNA libraries were labeled and hybridized with tiling
arrays as an alternative to cloning and sequencing (conventional IVV method).
doi:10.1371/journal.pone.0001646.g001
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from each selected sequence.
In vitro pull-down assay
Pull-down assay using the C-terminal fluorescence labeling
technique was performed as previously described [21], with some
modifications. The bait Jun and prey proteins were translated in
vitro separately. Only the preys were fluorescence-labeled in in vitro
translation. The bait and preys were incubated with affinity beads,
and captured prey proteins were electrophoresed and analyzed by
using a Molecular Imager FX (Bio-Rad). Details are given in
Methods S1 online.
Surface plasmon resonance analysis
SPRanalysiswasperformedonaBIACORE3000instrumentwith
a CM4 sensor chip conjugating anti-GST mAb (Biacore). GST-fused
candidate proteins were employed as ligands. Full-length mouse Jun
fused with a His-tag was employed as an analyte. The experiments
were performed under two conditions of analyte concentration
(500 nM and 250 nM). Details are given in Methods S1 online.
Results
Design of a transcription-factor tiling (TFT) array and
sample labeling
In affinity selection of protein interactions from randomly
fragmented cDNA libraries, relatively short cDNA fragments
encoding specific binding regions are often obtained. In order to
detect these fragments, we adopted a tiling array strategy for the
design of custom oligo DNA microarrays as follows: 1) Oligonucle-
otide probes of 50-mer in length were used. This is the preferred
length for microarray probes, because shorter probes result in low
sensitivity and longer probes produce non-specific signals [25]. 2)
There should be no gaps between the probes. A contiguous linear
series of data is required to recognize a signal peak in the algorithm
for tiling array analysis (in this case, at least 4 data points are needed
in a search window), so the probes must be densely arranged. 3)
mRNA sequences were employed for the tiling array. Only coding
regions are required for the purpose of protein-interaction analysis,
so other genomic sequences, e.g., introns, control regions and non-
coding RNAs, were not employed. In this study, we constructed
TFT arrays containing ,1,600 ORF sequences of known and
predicted mouse transcription-regulatory factors (334,372 oligonu-
cleotides) to analyze cDNA fragments from IVV screening for Jun (a
transcription factor)-interactors [21].
We also improved the method for labeling of cDNA samples.
Usually, double-stranded DNA samples for a tiling array analysis
are labeled by using random primers [26]. However, cDNA
fragments selected from a randomly fragmented cDNA library
[21] seem to be too short for efficient labeling by random priming.
Indeed, in a test analysis with a TFT array using the random
priming labeling method, we failed to detect all of the previously
detected candidates (data not shown). Therefore we employed
another labeling procedure [24], in which sense-strand labeled
RNAs were produced by one-step in vitro transcription using a SP6
promoter attached to cDNA fragments from IVV screening.
Identification of selected candidates using the TFT array
From the 5th-round DNA library of the IVV screening in the
presence and absence of a bait Jun protein, called bait (+) and bait
(2) screening, respectively [21], we obtained labeled RNAs and
hybridized them onto the tiling array. First, the ratios of the signal
intensities from the experiments in the presence and absence of
bait were calculated. The ratio data are presented in Data S1
online as a GFF formatted file. Next, we searched for signal peaks
in the data, as described in Methods. Only reproducible signal
peaks were collected (Table S1 online); the total number of peaks
was 647 on 545 mRNA sequences (some of the mRNA sequences
included multiple peaks). To distinguish between true positives and
false positives, specific enrichment of the selected candidates was
validated by real-time PCR. Among the top 10 percent of the
peaks (64 regions), specific enrichment of 35 peaks was confirmed
in the screening (white graph in Figure 2A; the signal intensity
and peak data of the 35 candidates are presented in Figure S1
online). The data indicate that the appropriate threshold for
distinguishing between true positives and noise in the microarray
signal is a signal ratio of 3,4.
The 35 candidates identified in the present study include all of
the 20 Jun-interactors identified in our previous studies using
conventional cloning and sequencing (Table 1) [21,22]. Further-
more, the 35 candidates include eight well-known Jun-associated
proteins, i.e., c-Maf, Fos, Jun, Atf7, Atf4, Jdp2, Atf3 and Fosl2
(Table 1), which is double the number in the previous study, in
which four known Jun-interactors were obtained (white graphs of
Figure 2B) [21,22]. In other words, 15 proteins including four
known Jun-interactors were newly detected using the TFT arrays.
Figure 2. Data from the tiling array. (A) The top 10% candidates were confirmed by real-time PCR. White and gray indicate numbers of enriched
and non-enriched candidates, respectively. (B) Numbers of known (white) and newly selected (gray) proteins from conventional sequencing and the
TFT arrays.
doi:10.1371/journal.pone.0001646.g002
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interactions
To confirm the physical association of the 11 newly discovered
candidates with Jun, we first performed in vitro pull-down assay.
Seven of the 11 tested candidates exhibited specific interaction
with the bZIP domain of Jun (Figure S2 online). The affinity of
the remaining four proteins, i.e., Cutl1, Myh11, Tax1bp1 and
Cebpz, for Jun may be weaker, because their enrichment ratios
(excluding that of Cutl1) in the IVV screening were lower than
those of others (Table 1). Thus, we next employed the surface
plasmon resonance (SPR) method, a highly sensitive analysis tool
for protein interactions. In this case, all of the candidates except
Tax1bp1 interacted with Jun in a concentration-dependent
fashion (Figure S3 online). Although most of the above tested
interactions seem to be very weak, we considered that the
interactions are true positives, because all of the candidates except
Cebpz contain leucine-heptad repeats in the selected regions, and
such repeats are an important motif for heterodimerization with
Jun. Further experiments in vivo will be required to examine the
physiological roles of these interactions.
Discussion
To evaluate the quality of the interaction data, coverage and
accuracy were calculated as follows. Jun interacts with many bZIP
superfamily proteins and structurally unrelated transcription
Table 1. Thirty-five selected proteins
Gene symbol
Cloning &
Sequencing Accession no. Signal ratio
Locus on mRNA
sequence (base)
Abundance ratio
in the initial
library (%)
Abundance ratio
in the 5th round
library (%) Enrichment
Nrbf2 + NM_025307.2 8.255 651…950 5.7E-4 4.8E-1 840
4732436F15Rik + XM_143418.3 8.134 2051…2300 1.1E-4 1.5E+0 14,000
c-Maf* - S74567.1 7.796 1805…2004 6.4E-5 5.2E-1 8,000
SNAP19 + NM_025925.1 7.734 1…250 1.6E-3 2.2E+1 14,000
Fos* + NM_010234.2 7.720 501…800 7.4E-5 1.5E+0 20,000
Mapre3 + NM_133350.1 7.714 601…950 9.2E-4 1.4E+0 1,600
Cspg6 + NM_007790.2 7.577 2151…2700 4.1E-4 1.0E+0 2,500
Kif5A (region C) + NM_008447.2 7.491 2251…2900 3.3E-3 4.3E+0 1,300
9130229H14Rik + XM_135706.4 7.487 51…400 1.6E-3 1.2E+07 3 0
Jun* + NM_010591.1 7.411 1701…1950 1.4E-4 4.3E-1 3,100
Mapk8ip3 + NM_013931.1 7.282 1351…1800 7.3E-4 5.3E-1 720
Creb3 - XM_131375.2 7.172 601…800 3.3E-4 2.6E-3 8
Kif5B (region C) - NM_008448.2 7.141 2801…3200 1.3E-3 1.2E-1 95
Nef3 + NM_008691.1 7.129 951…1300 8.2E-3 1.5E+01 9 0
Kif5C (region C) + NM_008449.2 7.106 2701…3200 2.2E-3 6.4E+0 2,900
Eef1d + NM_029663.1 7.083 1301…1750 5.5E-3 2.3E+04 2 0
Atf7* - NM_146065.1 6.999 1051…1300 2.7E-5 1.4E-1 5,000
Atf4* + NM_009716.1 6.991 1001…1300 5.4E-4 1.9E+0 3,500
Cutl1 - NM_009986.2 6.850 301…500 1.4E-3 3.2E-1 230
Jdp2* + NM_030887.2 6.768 451…700 7.1E-4 2.1E+0 3,000
Ofd1 - NM_177429.2 6.692 1752…2001 1.4E-4 2.6E-1 1,800
GFAP + NM_010277.1 6.551 901…1100 1.1E-3 8.8E-2 77
Kif5C (region N) + NM_008449.2 6.098 1201…1450 1.2E-2 5.2E+04 5 0
Psmc5 - NM_008950.1 5.961 51…300 3.5E-3 6.4E-2 19
Kif5B (region N) + NM_008448.2 5.937 1301…1550 6.4E-4 1.5E-1 230
Atf3* - NM_007498.2 5.574 401…950 1.1E-7 2.0E-2 180,000
B130050I23Rik + NM_153536.2 5.213 1151…1450 1.9E-4 1.5E-2 80
Cebpg - XM_133383.2 5.122 401…750 3.5E-5 2.7E-3 78
1200008A14Rik + NM_028915.1 4.623 1501…1750 3.6E-4 2.1E-1 600
Myh11 - NM_013607.1 4.343 3251…3650 1.4E-4 2.9E-4 2
Tax1bp1 - NM_025816.1 4.176 501…750 2.7E-3 1.0E-2 4
Myt1 - NM_008665.2 4.084 3251…3550 1.1E-5 1.3E-4 12
Fosl2* - NM_008037.3 3.935 401…750 2.1E-5 1.4E-2 670
Tef - NM_017376.2 3.467 851…1000 1.3E-4 1.1E-3 8
Cebpz - NM_009882.1 3.012 1451…1750 1.2E-4 3.7E-4 3
*Previously reported interactors with Jun.
doi:10.1371/journal.pone.0001646.t001
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sively collected reported Jun-interactors in their review, and the
number of mammalian Jun-interactors was 51 at that time [27].
Of the 51 interactors, some lack the potential to bind with the bait
Jun protein in our experiment for various reasons. For example,
the SMAD interacting region of Jun [28] was deleted from our
bait protein construct, and NFAT family proteins require a DNA
fragment including the AP-1 sequence [TGA(C/G)TCA] and
NFAT recognition element (GGAAAA) for stable interaction with
Jun [29]. Also, the expression of some of the interactors, e.g., JunD,
Fra1, Batf, MafA, Nrl and NF-IL16, was not confirmed in the
cDNA library used in this study (data not shown). In all, 29 Jun-
interactors were expressed in the cDNA library and were expected
to bind with the bait Jun protein used here. Of these 29 proteins,
four (14%) and eight (28%) were detected by the conventional
sequencing and by the newly introduced TFT array method,
respectively. This is a remarkable increase and confirms the value
of our new methodology as a screening tool for protein
interactions. While the coverage was increased considerably, the
accuracy did not decrease. Specifically, the number of false
positives did not increase: the rates of confirmation of proteins by
in vitro pull-down assays in the previous and present studies were
75% and 74%, respectively. Further, we confirmed by SPR that
most of the unbound candidates in the pull-down assay actually
interacted with Jun. These results indicate that generation of false
positives in this novel method is low, and that the method is
practical. Undetected remaining interactors were considered to be
false negatives. Mismatching of the selection conditions, e.g., salts,
detergents, and pH, or the bait construct, e.g., length, region, and
tags, might inhibit these interactions.
For quantitative analysis, the abundance ratios of 35 specifically
selected candidates in the initial and screened cDNA libraries were
determined by real-time PCR, and the enrichment rates
(abundance ratio in the 5th round library per that in the initial
library) were also calculated (Table 1). The abundance of the 15
newly found candidates (excluding c-Maf, Cutl1 and Ofd1) was
less than the theoretical threshold determined from the results of
our previous study (an analysis of 451 clones) [21,22]. In order to
detect the least abundant candidate (Myt1; 1.3610
24% of the
screened cDNA library) by cloning and sequencing, it would have
been necessary to analyze at least 1.0610
6 clones. These results
indicate that our new method is more sensitive, higher-throughput
and more cost-effective than the previous method.
From the standpoint of the detection sensitivity, the combinatorial
use of the IVV method with TFT arrays provides an extremely
sensitivemethodforprotein-interaction analysis,becauseeven avery
weakly expressed target, Atf3, could be detected in this study. In the
cDNA library before IVV screening, the content of fragments of the
selected region of Atf3 was 1.2610
27%. If one mRNA molecule
existed per cell, thecontentofa fragment of the gene wouldbeabout
1.2610
25 to 5.9610
25% (we employed the parameters from a
reference for this calculation [30], and the details are given in
Methods S1 online). Thus, the content of Atf3 mRNA in the initial
library corresponds to about one molecule per 20 to 100 cells. This
suggests that Atf3 is expressed at a very low level in a cell type that is
a minor component of whole mouse brain tissue. It is noteworthy
that targets expressed at such low levels can be detected without the
need for a cell purification procedure, e.g., collection of somatic stem
cells by flow cytometry. The high sensitivity of our method may
allow access to targets which would be hard to analyze with other
existing tools, e.g., the TAP method [18].
Among the newly detected Jun-associated protein candidates,
Cebpg, Creb3, and Tef are intriguing proteins as Jun-associated
transcriptional regulators, because they contain basic regions near
the leucine heptad motifs, which are necessary for binding with
regulatory sequences on the genomic DNA; many known Jun-
associated proteins contain such structures. Cebeg is a member of
the CAAT/enhancer-binding protein (C/EBP) family, which is
one of the largest and most highly conserved groups of eukaryotic
transcription factors. Cebpg is known to interact with Cebpb, a
member of the C/EBP family, but the function of the protein is
not well understood [31]. Davydov et al. indicated that Cebpg
binds to the positive regulatory element-I (PRE-I) of the human
interleukin-4 gene by forming a heterodimer with Fos protein.
However, the interaction between Cebpg and Jun was not clearly
delineated [32].Creb3isalsoatranscriptionalregulatorbelongingto
the cyclic AMP response element-binding (CREB)/activating
transcription factor (ATF) protein family. The bZIP region of Creb3
is strikingly similar to that of ATFa, a known partner of Jun [33]. Tef
is a member of the proline and acidic amino acid-rich basic leucine
zipper (PAR bZIP) transcription factor family. The PAR bZIP
proteins control circadian rhythms in tissues such as the suprachi-
asmatic nucleus and the liver. Mice deficient in all three PAR bZIP
proteins are highly susceptible to generalized spontaneous and
audiogenic epilepsies that are frequently lethal [34]. No information
is available about the functional relationship between Tef and Jun.
More detailed studies in vivo may reveal novel and unexpected
functions of Jun in combination with these proteins.
In summary, we have applied tiling array technology, which has
previously been used for ChIP-chip assays [26] and transcriptome
analyses [20], to protein-interaction analysis with an in vitro display
technique for the first time. Compared with previous results
obtained with cloning and sequencing [21,22], use of the tiling
array greatly increased the coverage of known Jun-interactors
from 14% to 28% without any decrease of accuracy (,75%). The
new method can also detect targets expressed at extremely low
levels. We believe that this highly sensitive and reliable method has
the potential to be used widely, because the tiling array method
can easily be extended to genome-wide scale, even though the
search space is limited in tiled sequences, and the method can also
be used in combination with other display technologies, such as
phage display and ribosome display.
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